The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency ( EMEA ).

The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU) responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.

Dec 17, 2024 · In 2024, we recommended 114 new medicines for human use, of which 48 contain a completely new active substance and 16 are for the treatment of rare diseases. It is the first time since 2009 that we have been able to deliver more than 100 positive opinions.

From June 2022 Prof Thistrup is the Chief Medical Officer of the European Medicines Agency. Alberto Ganan Jimenez is a Pharmacist and a Biochemist and holds a PhD on Molecular and Cell Biology from University of Zaragoza (Spain).

The European Medicines Agency (EMA) publishes details of the members of its Management Board. This page lists each Management Board member's and alternate's: affiliation; curriculum vitae; declaration of interests and confidentiality undertaking.

Nov 24, 2020 · Emer Cooke, formerly Director with the World Health Organization, began her new role as Executive Director of the European Medicines Agency (EMA) last week (November 16, 2020). She succeeds Guido Rasi, who completed his second term as Executive Director this month (November 2020).

What are the key items on your priority list up to the end of your term as executive director of EMA in 2025? As regulators, we have a great opportunity to build on the COVID experience and make sure that we are part of an ecosystem that brings new products which can make a …

The European Medicines Agency (EMA) protects and promotes human and animal health by evaluating and monitoring medicines within the European Union (EU) and the European Economic Area (EEA). The Agency's main responsibilities are authorising and monitoring medicines in the EU.

Competent authorities are organizations who are responsible for the regulation of medicinal products for human use in the European Economic Area. The HMA is supported by working groups and by the HMA Management Group and Permanent Secretariat. The HMA co-operates with the EMA and the EC in the operation of the European Medicines Regulatory Network.

In the European Union (EU), the medicines regulatory network, comprised of the National Competent Authorities (NCAs) in EU Member States (MSs), the European Medicines Agency (EMA) and the European Commission (EC), played a key role in the response to the pandemic.